Cover Image

Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Pierre Chelle, Dagmar Hajducek, Emma Iserman, Alfonso Iorio, Andrea Edginton
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Haemophilia
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi‐country severe WAPPS‐Hemo haemophilia patients
by: Dagmar M. Hajducek, et al.
Published: (2024)

A Global Cross‐Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
by: Dagmar M. Hajducek, et al.
Published: (2025)

Health utilities in adults with hemophilia A: A retrospective cohort study
by: Sam Hirniak, et al.
Published: (2024)

Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
by: Davide Matino, et al.
Published: (2024)

Evaluation of the Burden of Bone Fractures in People Living With Haemophilia: A Registry‐Based Matched Cohort Study
by: Federico Germini, et al.
Published: (2026)

Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources
by: Federico Germini, et al.
Published: (2025)

Developing a Two‐Sided Decision Box to Facilitate Shared Decision‐Making for Switching From Conventional to Pharmacokinetic‐Tailored Prophylaxis in Haemophilia
by: Arun Keepanasseril, et al.
Published: (2025)

Monitoring of Nonacog Beta Pegol: One‐Stage Clotting Assay With Kaolin Reagent as a Practical Alternative to Chromogenic Methods
by: Marie Prudková, et al.
Published: (2025)

A Psychometric Analysis of the Haemophilia Quality of Life Questionnaire for Adults Physical Health Subscale and Total Scores: Data From the Phase 3 XTEND‐1 Trial in Patients With Severe Haemophilia A
by: Jérôme Msihid, et al.
Published: (2026)

Perioperative Outcomes in Factor XI Deficiency: A Systematic Review
by: Zainab Al‐Housni, et al.
Published: (2026)

Global Comparative Antithrombin Field Study: Impact of Laboratory Assay Variability on the Assessment of Antithrombin Activity Measurement at Fitusiran Clinical Decision‐Making Points
by: Ekta Seth Chhabra, et al.
Published: (2025)

Optimizing Perioperative Management of Haemophilia B With rFIX‐FP: Pharmacokinetic Validation of the Hemoptidose Tool
by: Xavier Delavenne, et al.
Published: (2026)

Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study
by: Randall Curtis, et al.
Published: (2024)

National Bleeding Disorder Foundation Clinical Practice Recommendations for Laboratory Screening of Iron Deficiency With and Without Anemia in the Inherited Bleeding Disorders Population
by: Glaivy Batsuli, et al.
Published: (2026)

The Value of Public Inquiries, Ethical Accountability, and Patient Voices: Reflections on the Infected Blood Inquiry
by: Richard Gorman, et al.
Published: (2026)

Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’
by: Ann‐Cristin Berkemeier, et al.
Published: (2025)

Management of Major Orthopaedic Surgery in a Patient With the Rare Thrombomodulin c.1611C>a Mutation: A Case of an Uncommon Bleeding Disorder
by: Béatrice Ferrey, et al.
Published: (2025)

Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment
by: Yesim Dargaud, et al.
Published: (2025)

Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa
by: Michael Iarossi, et al.
Published: (2026)

The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
by: Glenn F. Pierce, et al.
Published: (2025)

Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe Haemophilia
by: Ana Mendoza, et al.
Published: (2025)

Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry
by: Kathelijn Fischer, et al.
Published: (2025)

Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients
by: Michael Dong, et al.
Published: (2026)

Personal, Social, Economic Impacts on Haemophilia A Patients and Caregivers: A Mixed Method Study (WE CARE)
by: Mridul Makkar, et al.
Published: (2026)

Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study
by: Anna Olsson, et al.
Published: (2025)

Clinical, Phenotypic and Genotypic Characteristics of Von Willebrand Disease in Afro‐Caribbeans: Results From a Study in Martinique Island, French West Indies
by: Marie‐Daniéla Dubois, et al.
Published: (2025)

Determining the Impact of Combination Oral Contraceptives on Von Willebrand Factor and Factor VIII in Healthy Patients and Patients With Von Willebrand Disease: A Scoping Review and Meta‐Analysis
by: Eve Justason, et al.
Published: (2025)

Acupuncture for Chronic Pain Management in Haemophilic Arthropathy: A Systematic Review
by: Andrea Demeco, et al.
Published: (2025)

The Swiss Haemophilia Registry–Report From the First 8 Years
by: Alessandra Bosch, et al.
Published: (2026)

European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice
by: Mathieu Fiore, et al.
Published: (2025)

Heterozygous large deletion mimicking homozygous substitution in MCFD2 in a patient with combined Factor V and Factor VIII deficiency
by: Hamdi Rezigue, et al.
Published: (2024)

Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures
by: Dominique Desprez, et al.
Published: (2024)

Effect of the Polymorphic Variant p.D1472H on the Platelet‐Dependent VWF Activity Assays
by: Omid Seidizadeh, et al.
Published: (2025)

Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series
by: Kimberley Youkhana, et al.
Published: (2024)

Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B
by: Brigitte Tardy‐Poncet, et al.
Published: (2024)

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis
by: Hermann Eichler, et al.
Published: (2026)

Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging
by: Roberta Gualtierotti, et al.
Published: (2024)

Hemophilia Severity and Its Association With Mental Health and Health‐Related Quality of Life—Results From a Cross‐Sectional Multicenter Study
by: Francesca Schmitt, et al.
Published: (2026)

Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real‐Life Case Series and Literature Review
by: Gaetano Giuffrida, et al.
Published: (2025)

International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
by: Björn Lundin, et al.
Published: (2024)